LRG1 and pancreatic neoplasm: In previous literatures, LRG1 showed promise to indicate inflammation in a mouse model, granulocytic differentiation [51], and was listed as one of the altered proteins in cancer proteomic studies, such as hepatocellular carcinoma [52], pancreatic cancer [53], and lung cancer [32].